Description
THIS MODIFICATION IS FOR THE ADDITION OF CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS.
Base award description: BD SARS-COV-2 TESTING REAGENTS
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-07-12+$32,997= $32,997
- Mod P000012023-10-01+$504,304= $537,301
- Mod P000032024-10-01+$219,980= $757,281
- Mod P000022025-01-29-$172,134= $585,147
- Mod P000052025-10-02-$109,990= $475,157
- Mod P000062026-06-02+$0= $475,157
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-07-12 | +$32,997 | $32,997 | BD SARS-COV-2 TESTING REAGENTS |
| Mod P00001· EXERCISE AN OPTION | 2023-10-01 | +$504,304 | $537,301 | BD SARS-COV-2 TESTING REAGENTS |
| Mod P00003· EXERCISE AN OPTION | 2024-10-01 | +$219,980 | $757,281 | BD SARS-COV-2 TESTING REAGENTS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-01-29 | −$172,134 | $585,147 | BD SARS-COV-2 TESTING REAGENTS |
| Mod P00005· FUNDING ONLY ACTION | 2025-10-02 | −$109,990 | $475,157 | DE-OBLIGATION OF EXCESS FUNDS FOR BD SARS-COV-2 TESTING REAGENTS |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2026-06-02 | +$0 | $475,157 | THIS MODIFICATION IS FOR THE ADDITION OF CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTOR… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6550 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526A0045 | ABBOTT LABORATORIES INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $0 | FY2026 |
| 36C24526P0222 | CEPHEID | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $42,410 | FY2026 |
| 36C24526P0181 | FISHER SCIENTIFIC COMPANY L.L.C. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $184,136 | FY2026 |
| 36C24526N0207 | FISHER SCIENTIFIC COMPANY L.L.C. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $68,147 | FY2026 |
| 36C24526P0098 | BECTON, DICKINSON AND COMPANY | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $147,352 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24523P0577_3600_-NONE-_-NONE- · retrieved 2026-09-26.